Design and synthesis of tunable schiff base complexes from bis-(2-oxoindolin-3-ylidene)anthracene-9,10-dione: Integrated structural, biological, and molecular modeling insights
Ahmed M. Abu-Dief , Eida S. Al-Farraj , Mohamed Abdel-Hameed , Nadiyah Alahmadi , Maher Fathalla , Abdullah Yahya Abdullah Alzahrani , Mashael A. Alghamdi , Aly Abdou
{"title":"Design and synthesis of tunable schiff base complexes from bis-(2-oxoindolin-3-ylidene)anthracene-9,10-dione: Integrated structural, biological, and molecular modeling insights","authors":"Ahmed M. Abu-Dief , Eida S. Al-Farraj , Mohamed Abdel-Hameed , Nadiyah Alahmadi , Maher Fathalla , Abdullah Yahya Abdullah Alzahrani , Mashael A. Alghamdi , Aly Abdou","doi":"10.1016/j.compbiolchem.2025.108682","DOIUrl":null,"url":null,"abstract":"<div><div>Three novel compounds, each featuring a tetra-dentate ligand known as 1-((2-oxoindolin-3-ylidene)amino)-2-((2-oxoindolin-3-ylidene)amino)anthracene-9,10-dione (BIA), have been successfully synthesized. These molecules exhibit the unique characteristic of forming complexes with Cu(II), Ru(III), and VO(II) metal ions, resulting in distinct metal-organic structures.Structural characterization was performed using elemental analysis, magnetic properties measurement, FT-IR spectroscopy, and electronic spectroscopy. Moreover, the stoichiometry in solution was determined through both continuous variation and molar ratio analysis. These analyses have shown that the copper and ruthenium complexes exhibit an octahedral geometric configuration. Conversely, the vanadyl (VO) complex demonstrates a distinct square pyramidal structure.Density functional theory (DFT) computations were employed to confirm the geometrical configurations of the prepared complexes. The synthesized <strong>BIA</strong> ligand and its corresponding metal complexes were assessed for their <em>in vitro</em> antimicrobial. The results indicated that the RuBIA complex emerged as the most efficacious agent against both bacterial and fungal growth, outperforming established medications like Ofloxacin and Fluconazole as standard drugs with sequence<strong>BIA < VOBIA < CuBIA <RuBIA</strong>complex.Additionally, the study evaluated the in vitro cytotoxicity of the synthesized compounds against Hep-G2, MCF-7, and HCT-116 cancer cell lines. The results suggested that the <strong>RuBIA</strong> complex had the highest potency (IC50 =3.42–6.45 <strong>µg/µl)</strong>, followed by <strong>CuBIA</strong>(IC50 =4.42–7.85 <strong>µg/µl)</strong>, and <strong>VOBIA</strong>(IC50 =5.72–8.35 <strong>µg/µl)</strong>, indicating their potential as promising anticancer agents. The DPPH radical scavenging activity was also assessed, and all complexes displayed greater efficacy than Ascorbic acid. Investigations employing molecular docking methodologies were undertaken to discern the interaction mechanisms of the aforementioned complexes. The findings revealed that the incorporation of metal ions substantially bolstered the molecular affinities, with the sequence of binding potency as follows: RuBIA> CuBIA > VOBIA complex>BIA ligand.</div></div>","PeriodicalId":10616,"journal":{"name":"Computational Biology and Chemistry","volume":"120 ","pages":"Article 108682"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Computational Biology and Chemistry","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1476927125003433","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Three novel compounds, each featuring a tetra-dentate ligand known as 1-((2-oxoindolin-3-ylidene)amino)-2-((2-oxoindolin-3-ylidene)amino)anthracene-9,10-dione (BIA), have been successfully synthesized. These molecules exhibit the unique characteristic of forming complexes with Cu(II), Ru(III), and VO(II) metal ions, resulting in distinct metal-organic structures.Structural characterization was performed using elemental analysis, magnetic properties measurement, FT-IR spectroscopy, and electronic spectroscopy. Moreover, the stoichiometry in solution was determined through both continuous variation and molar ratio analysis. These analyses have shown that the copper and ruthenium complexes exhibit an octahedral geometric configuration. Conversely, the vanadyl (VO) complex demonstrates a distinct square pyramidal structure.Density functional theory (DFT) computations were employed to confirm the geometrical configurations of the prepared complexes. The synthesized BIA ligand and its corresponding metal complexes were assessed for their in vitro antimicrobial. The results indicated that the RuBIA complex emerged as the most efficacious agent against both bacterial and fungal growth, outperforming established medications like Ofloxacin and Fluconazole as standard drugs with sequenceBIA < VOBIA < CuBIA <RuBIAcomplex.Additionally, the study evaluated the in vitro cytotoxicity of the synthesized compounds against Hep-G2, MCF-7, and HCT-116 cancer cell lines. The results suggested that the RuBIA complex had the highest potency (IC50 =3.42–6.45 µg/µl), followed by CuBIA(IC50 =4.42–7.85 µg/µl), and VOBIA(IC50 =5.72–8.35 µg/µl), indicating their potential as promising anticancer agents. The DPPH radical scavenging activity was also assessed, and all complexes displayed greater efficacy than Ascorbic acid. Investigations employing molecular docking methodologies were undertaken to discern the interaction mechanisms of the aforementioned complexes. The findings revealed that the incorporation of metal ions substantially bolstered the molecular affinities, with the sequence of binding potency as follows: RuBIA> CuBIA > VOBIA complex>BIA ligand.
期刊介绍:
Computational Biology and Chemistry publishes original research papers and review articles in all areas of computational life sciences. High quality research contributions with a major computational component in the areas of nucleic acid and protein sequence research, molecular evolution, molecular genetics (functional genomics and proteomics), theory and practice of either biology-specific or chemical-biology-specific modeling, and structural biology of nucleic acids and proteins are particularly welcome. Exceptionally high quality research work in bioinformatics, systems biology, ecology, computational pharmacology, metabolism, biomedical engineering, epidemiology, and statistical genetics will also be considered.
Given their inherent uncertainty, protein modeling and molecular docking studies should be thoroughly validated. In the absence of experimental results for validation, the use of molecular dynamics simulations along with detailed free energy calculations, for example, should be used as complementary techniques to support the major conclusions. Submissions of premature modeling exercises without additional biological insights will not be considered.
Review articles will generally be commissioned by the editors and should not be submitted to the journal without explicit invitation. However prospective authors are welcome to send a brief (one to three pages) synopsis, which will be evaluated by the editors.